Wang Wei, Xu Yongbo, Zhang Bohao, Liu Shuling, Ma Zhenjian, Wang Sifei, Zhang Pinyuan, Wei Ming
Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin, China.
Front Neurol. 2024 Jan 12;14:1280181. doi: 10.3389/fneur.2023.1280181. eCollection 2023.
The retrograde semi-retrieval technique (RESET) has been described as a modified technique for endovascular thrombectomy (EVT) whose safety and efficacy for intracranial atherosclerosis stenosis (ICAS) patients remain uncertain. This article presents our single-center experience, comparing RESET vs. non-RESET in ICAS patients.
We analyzed 327 consecutive ICAS patients who underwent EVT at Tianjin Huanhu Hospital from January 2018 and December 2022. Patients were categorized into two groups: RESET and non-RESET. The primary outcome was the first-pass effect (FPE). Secondary outcomes included successful reperfusion, functional independence at 90 days, mortality, and symptomatic intracranial hemorrhage (sICH).
RESET was significantly associated with FPE [adjusted odds ratio (aOR) 2.00, 95% confidence interval (CI) 1.03-3.87, = 0.040]. RESET was not significantly associated with successful reperfusion (aOR 1.5, CI 0.55-4.06, = 0.425), an mRS of 0-2 at 90 days (aOR 1.36, CI 0.83-2.21, = 0.223), sICH (aOR 0.39, CI 0.12-1.23, = 0.108), and mortality (aOR 0.49, CI 0.16-1.44, = 0.193). After propensity score matching, the results were consistent with the primary analysis.
Compared to non-RESET, patients treated with RESET showed increased FPE incidence and significantly decreased puncture-to-reperfusion time. RESET was proven to be safe and effective in enhancing reperfusion for LVO patients receiving EVT with underlying ICAS.
逆行半回收技术(RESET)已被描述为一种用于血管内血栓切除术(EVT)的改良技术,其对颅内动脉粥样硬化狭窄(ICAS)患者的安全性和有效性仍不确定。本文介绍了我们单中心在ICAS患者中比较RESET与非RESET的经验。
我们分析了2018年1月至2022年12月在天津环湖医院接受EVT的327例连续ICAS患者。患者分为两组:RESET组和非RESET组。主要结局是首次通过效应(FPE)。次要结局包括成功再灌注、90天时的功能独立、死亡率和症状性颅内出血(sICH)。
RESET与FPE显著相关[调整后的优势比(aOR)为2.00,95%置信区间(CI)为1.03-3.87,P = 0.040]。RESET与成功再灌注(aOR为1.5,CI为0.55-4.06,P = 0.425)、90天时改良Rankin量表(mRS)评分为0-2(aOR为1.36,CI为0.83-2.21,P = 0.223)、sICH(aOR为0.39,CI为0.12-1.23,P = 0.108)和死亡率(aOR为0.49,CI为0.16-1.44,P = 0.193)均无显著相关性。倾向评分匹配后,结果与初步分析一致。
与非RESET相比,接受RESET治疗的患者FPE发生率增加,穿刺至再灌注时间显著缩短。事实证明,RESET在增强接受EVT治疗且伴有ICAS的大血管闭塞(LVO)患者的再灌注方面是安全有效的。